Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study

Journal of Pharmaceutical Policy and Practice

Xavier Nsabagasani¹  Freddie Ssengooba¹  Jasper Ogwal-Okeng¹  Herbert Muyinda¹  James Mugisha¹  Ebba Hansen¹  Anthony Mbonye¹ 

[1] Child Health and Development Center, College of Health Sciences, Makerere University, P.O. Box 6717, Kampala, Uganda

关键词: Children;    Child-appropriate dosage formulations;    Stakeholders;    Policy transfer;    Child size medicines and Uganda;   

DOI  :  10.1186/s40545-015-0039-1

学科分类：药理学

来源: BioMed Central

【 摘 要 】

Background

In 2007, the Sixtieth World Health Assembly (WHA) passed a resolution entitled “Better medicines for children” and subsequently the World Health Organization (WHO) recommended the inclusion of child-appropriate dosage formulations in the essential medicines lists of member countries. However, child-appropriate dosage formulations are not highlighted in the Essential Medicines and Health Supplies List of Uganda (EMHSLU) 2012 and they are still limited in availability in public health facilities. Several stakeholders influenced the status of child-appropriate dosage formulations in the EMHSLU 2012.

【 授权许可】

Unknown